Cases & Deals

Bryan, Garnier & Co Limited and Chardan Capital Markets complete €25 million private placement of shares by GenSight Biologics S.A.

Clients Bryan, Garnier & Co Limited and Chardan Capital Markets, LLC

Jones Day represented Bryan, Garnier & Co Limited and Chardan Capital Markets, LLC in connection with the €25 million private placement of shares by GenSight Biologics S.A., a French clinical-stage gene therapy company in the area of severe retinal neurodegenerative diseases.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.